We are live on ! Find out more
CPHI icon

China Pharma Holdings

7 hedge funds and large institutions have $424K invested in China Pharma Holdings in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 77 (0)

0% less ownership

Funds ownership: 0.01%0% (-0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

39% less capital invested

Capital invested by funds: $695K → $424K (-$271K)

Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$222K -$131K -481 -34%
BCM
2
Bridgeway Capital Management
Texas
$94K
VF
3
Virtu Financial
New York
$51K +$39.6K +145 +220%
HF
4
HRT Financial
New York
$30K -$120K -440 -78%
Two Sigma Advisers
5
Two Sigma Advisers
New York
$15K +$9.55K +35 +125%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$11K +$12.6K +46 New
FCT
7
First Community Trust
Iowa
$724 +$819 +3 New
UBS Group
8
UBS Group
Switzerland
-$11K -39 Closed

CPHI Hedge Fund Activity: Q4 2021 in Review

7 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2021, worth a combined $424K — down 39% from $695K a quarter earlier.

Fund positioning in CPHI was balanced in Q4 2021: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was Virtu Financial, adding an estimated $39.6K. The largest seller was Renaissance Technologies, cutting an estimated $131K.

  • 7 institutional investors held China Pharma Holdings (CPHI) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $424K of China Pharma Holdings stock for Q4 2021, down 39% quarter-over-quarter.
  • 2 funds opened new China Pharma Holdings positions in Q4 2021 and 2 closed out, a net change of 0 holders.
  • The largest China Pharma Holdings buyer in Q4 2021 was Virtu Financial, an estimated $39.6K added.
  • The largest China Pharma Holdings seller in Q4 2021 was Renaissance Technologies, an estimated $131K sold.

Based on aggregated 13F filings for Q4 2021.